Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Janus II Feasibility

NCT: NCT06556693 · RECRUITING

NCT IDNCT06556693
StatusRECRUITING
Start Date2025-08-12
SponsorZoll Medical Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

The objectives of this study are to evaluate the feasibility of the remedē® Dual Channel System at implant and overnight sleep studies and to assess chronic safety.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑